A revenue-generating, small-cap Canadian pharmaceutical company

Revenue Projected at $150,000,000 by 2025

Free
Discussion Forum: Valeo Pharma Inc.
List Message View
Thread Message View
New Message
Author / Date /
Topic Title
Rating
Re
Last Post
AGORACOM-KE - Jun 29, 2021 09:39AM
Icon agoracom Valeo Pharma Closes $11.5 Million Bought-Deal Public Offering, Including Full Exercise of the Over-Allotment Option

0
AGORACOM-KE
Jun 29, 2021 09:39AM
AGORACOM - Jun 28, 2021 01:12PM
Icon agoracom CLIENT FEATURE: Valeo Pharma (VPH: CSE) (VPHIF: OTCQB) An Innovative CDN Pharma Company Projecting $160M In Annual Revenue by 2025

0
AGORACOM
Jun 28, 2021 01:12PM
AGORACOM-KE - Jun 23, 2021 08:04AM
Icon agoracom Valeo Pharma to Report Second Quarter 2021 Results and Hold Investors Conference Call / Webcast

0
AGORACOM-KE
Jun 23, 2021 09:04AM
AGORACOM - Jun 22, 2021 07:00AM
Icon agoracom Valeo Pharma Announces Commercial Launch of Enerzair® Breezhaler® and Atectura® Breezhaler®

0
AGORACOM
Jun 22, 2021 07:00AM
AGORACOM - Jun 11, 2021 04:17PM
Icon agoracom AGORACOM Small Cap 60: Valeo Pharma’s New Asthma Drugs Provide SIGNIFICANT Improvement to Current Standard of Care, Addresses Annual $700M CAD Market

0
AGORACOM
Jun 11, 2021 04:17PM
AGORACOM - Jun 09, 2021 09:56AM
Icon agoracom IIROC Trade Resumption - VPH

0
AGORACOM
Jun 09, 2021 09:56AM
AGORACOM - Jun 08, 2021 03:52PM
Icon agoracom Valeo Pharma Announces $10.0 Million Bought-Deal Public Offering of Units

0
AGORACOM
Jun 08, 2021 03:52PM
AGORACOM - Jun 08, 2021 03:45PM
Icon agoracom IIROC Trading Halt - VPH

0
AGORACOM
Jun 08, 2021 03:45PM
AGORACOM - Jun 04, 2016 06:23PM
Icon agoracom VIDEO – Valeo Pharma (VPH: CSE) Projecting Record Q2 Revenue As New Drugs Hit The Market. Next Drug Hits Market June 21. Targeting $150M Revenue...
1
0
AGORACOM
Jun 06, 2021 07:05PM
AGORACOM - Jun 03, 2021 11:49AM
Icon agoracom INTERVIEW ALERT: Valeo Pharma (VPH: CSE) (VPHIF: OTCQB)

0
AGORACOM
Jun 03, 2021 11:49AM
AGORACOM - Jun 01, 2021 07:00AM
Icon agoracom Valeo Pharma Provides Update on Private Payer Reimbursement for Enerzair® Breezhaler® and Atectura® Breezhaler®

0
AGORACOM
Jun 01, 2021 07:00AM
AGORACOM - May 26, 2021 07:00AM
Icon agoracom Valeo Pharma Projecting Record Revenues for Second Quarter 2021

0
AGORACOM
May 26, 2021 07:00AM
AGORACOM - May 25, 2021 02:40PM
Icon agoracom CLIENT FEATURE: Valeo Pharma (VPH: CSE) (VPHIF: OTCQB) An Innovative CDN Pharma Company Projecting $160M In Annual Revenue by 2025

0
AGORACOM
May 25, 2021 02:40PM
AGORACOM - May 17, 2021 07:00AM
Icon agoracom Valeo Pharma Joins Innovative Medicines Canada

0
AGORACOM
May 17, 2021 07:00AM
AGORACOM - May 07, 2021 10:28AM
Icon agoracom AGORACOM Small Cap 60: Valeo’s Blood Clot Prevention Drug Approved By Ont Drug Plan, Other Provinces To Follow Suit

0
AGORACOM
May 07, 2021 10:28AM
AGORACOM - May 05, 2021 10:33AM
Icon agoracom AGORACOM Small Cap 60: Valeo’s Blood Thinner Drug To Be Covered Under Ont Drug Benefit, Addresses $75M Provincial Market

0
AGORACOM
May 05, 2021 10:33AM
AGORACOM - May 03, 2021 02:01PM
Icon agoracom AGORACOM Small Cap 60: Valeo’s Blood Thinner Drug To Be Covered Under Ont Drug Benefit, Projected to Add $30M / Year in Revenue

0
AGORACOM
May 03, 2021 02:01PM
AGORACOM - Apr 29, 2021 05:13PM
Icon agoracom VIDEO - Valeo Pharma (VPH:CSE) Drug Projected To Add $30M / Year Revenue Gets Ontario Public Drug Coverage

0
AGORACOM
Apr 29, 2021 05:13PM
AGORACOM - Apr 29, 2021 07:00AM
Icon agoracom Valeo Pharma Announces Voting Results of its 2021 Annual General and Special Meeting of Shareholders

0
AGORACOM
Apr 29, 2021 07:00AM
AGORACOM - Apr 28, 2021 05:12PM
Icon agoracom INTERVIEW ALERT: Valeo Pharma (VPH: CSE) (VPHIF: OTCQB)

0
AGORACOM
Apr 28, 2021 05:12PM
New Message